1. Noninvasive serum N-glycans associated with ovarian cancer diagnosis and precancerous lesion prediction
- Author
-
Si Liu, Chang Tu, Haobo Zhang, Hanhui Huang, Yuanyuan Liu, Yi Wang, Liming Cheng, Bi-Feng Liu, Kang Ning, and Xin Liu
- Subjects
Ovarian cancer ,Serum ,Orthogonal strategies ,N-glycome ,Early diagnosis ,Gynecology and obstetrics ,RG1-991 - Abstract
Abstract Background Ovarian cancer (OC) is one of the most common gynecological tumors with high morbidity and mortality. Altered serum N-glycome has been observed in many diseases, while the association between serum protein N-glycosylation and OC progression remains unclear, particularly for the onset of carcinogenesis from benign neoplasms to cancer. Methods Herein, a mass spectrometry based high-throughput technique was applied to characterize serum N-glycome profile in individuals with healthy controls, benign neoplasms and different stages of OC. To elucidate the alterations of glycan features in OC progression, an orthogonal strategy with lectin-based ELISA was performed. Results It was observed that the initiation and development of OC was associated with increased high-mannosylationand agalactosylation, concurrently with decreased total sialylation of serum, each of which gained at least moderately accurate merits. The most important individual N-glycans in each glycan group was H7N2, H3N5 and H5N4S2F1, respectively. Notably, serum N-glycome could be used to accurately discriminate OC patients from benign cohorts, with a comparable or even higher diagnostic score compared to CA125 and HE4. Furthermore, bioinformatics analysis based discriminative model verified the diagnostic performance of serum N-glycome for OC in two independent sets. Conclusions These findings demonstrated the great potential of serum N-glycome for OC diagnosis and precancerous lesion prediction, paving a new way for OC screening and monitoring.
- Published
- 2024
- Full Text
- View/download PDF